Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Catalyst Pharmaceuticals revenue
Catalyst Pharmaceuticals's revenue is $491.7 million.
What is Catalyst Pharmaceuticals's revenue?
- Catalyst Pharmaceuticals's revenue growth from 2010 to 2024 is 100,467.74%.
- Catalyst Pharmaceuticals has 51 employees, and the revenue per employee ratio is $9,641,843.
- Catalyst Pharmaceuticals's peak quarterly revenue was $141.8M in 2024(q4).
- Catalyst Pharmaceuticals peak revenue was $491.7M in 2024.
- Catalyst Pharmaceuticals annual revenue for 2023 was 398.2M, 85.9% growth from 2022.
- Catalyst Pharmaceuticals annual revenue for 2024 was 491.7M, 23.49% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Catalyst Pharmaceuticals historical revenue
Catalyst Pharmaceuticals's peak revenue was $491.7M in 2024. The peak quarterly revenue was $141.8M in 2024(q4).
Catalyst Pharmaceuticals's revenue increased from $489.0k in 2010 to $491.7M currently. That's a 100,467.74% change in annual revenue.
Catalyst Pharmaceuticals annual revenue
Catalyst Pharmaceuticals annual revenue over time
| Fiscal year / year | Catalyst Pharmaceuticals revenue |
|---|---|
| 2010 | $488,958 |
| 2018 | $500,000 |
| 2019 | $102.3M |
| 2020 | $119.1M |
| 2021 | $140.8M |
| 2022 | $214.2M |
| 2023 | $398.2M |
| 2024 | $491.7M |
How accurately did Catalyst Pharmaceuticals' revenue projections match actual performance?
Catalyst Pharmaceuticals annual growth
Catalyst Pharmaceuticals saw the greatest revenue growth in 2019, when revenue increased by 20,361.2%.
Catalyst Pharmaceuticals had the lowest revenue growth in 2018, when revenue changed by 2.26%.
Catalyst Pharmaceuticals annual growth rate over time
| Year | Catalyst Pharmaceuticals growth |
|---|---|
| 2018 | 2%↑ |
| 2019 | 20361%↑ |
| 2020 | 16%↑ |
| 2021 | 18%↑ |
| 2022 | 52%↑ |
| 2023 | 86%↑ |
| 2024 | 23%↑ |
Catalyst Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Catalyst Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2010 | - | - | - | $487,816 |
| 2018 | - | - | - | $499,232 |
| 2019 | $12.4M | $28.8M | $30.9M | $30.1M |
| 2020 | $29.1M | $29.6M | $29.3M | $31.0M |
| 2021 | $30.2M | $36.4M | $36.0M | $38.3M |
| 2022 | $43.1M | $53.1M | $57.2M | $60.8M |
| 2023 | $85.4M | $99.6M | $102.7M | $110.6M |
| 2024 | $98.5M | $122.7M | $128.7M | $141.8M |
Catalyst Pharmaceuticals jobs nearby
Do you work at Catalyst Pharmaceuticals?
Did Catalyst Pharmaceuticals meet its revenue projections?
Catalyst Pharmaceuticals financial information
| CEO | Patrick J. McEnany |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 51 |
| Date Founded | 2002 |
| Headquarters | Coral Gables, Florida |
| Number of Locations | 1 |
| Revenue | $491.7M |
| Net Income | $83,079,000 |
| Gross Proft | $422.9M (2024) |
| PE Ratio | 1.42 |
| Tax Rate | 0.2% |
| Market Capitalization | $232.5M |
| Total Assets | $375,630,000 |
| Ticker | CPRX |
Catalyst Pharmaceuticals jobs you might like
Catalyst Pharmaceuticals financing
Catalyst Pharmaceuticals received early financing of $489.0K on 2010-11-01.
| Series | Round size | Date |
|---|---|---|
| Grant | $489K | 11/2010 |
| Post Ipo Equity | $3.2M | 10/2011 |
| Post Ipo Equity | $15.1M | 09/2013 |
| Post Ipo Equity | $26.8M | 04/2014 |
| Post Ipo Equity | $34.7M | 02/2015 |
| Post Ipo Equity | $53.6M | 11/2017 |
Catalyst Pharmaceuticals investors
| Investors | Security type |
|---|---|
| New Leaf Venture Partners | Post Ipo Equity |
Catalyst Pharmaceuticals competitors
Catalyst Pharmaceuticals's top competitor, Merck, earned an annual revenue of $64.2B.
Catalyst Pharmaceuticals's smallest competitor is American Medical Association with revenue of $40.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Sanofi Genzyme | $84,495 | $4.6B | 12,000 | - |
| Emergent BioSolutions | $77,521 | $1.6B | 1,834 | 8 |
| Geron | $56,851 | $77.0M | 15 | 2 |
| Agency for Healthcare Research and Quality | $63,164 | $93.0M | 1,996 | - |
| Merck | $90,328 | $64.2B | 74,000 | 1,849 |
| WebMD | $93,501 | $705.0M | 1,800 | 139 |
| American Medical Association | $53,742 | $40.0M | 1,745 | 751 |
| The Jackson Laboratory | $51,784 | $331.1M | 7 | 59 |
| Substance Abuse and Mental Health Services Administration | $39,730 | $46.0M | 750 | - |
Catalyst Pharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Catalyst Pharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of Catalyst Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Catalyst Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Catalyst Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Catalyst Pharmaceuticals. The data presented on this page does not represent the view of Catalyst Pharmaceuticals and its employees or that of Zippia.
Catalyst Pharmaceuticals may also be known as or be related to CATALYST PHARMACEUTICALS INC., Catalyst Pharmaceuticals, Catalyst Pharmaceuticals Inc, Catalyst Pharmaceuticals Partners and Catalyst Pharmaceuticals, Inc.